David K. R. Karaolis
Center for Vaccine Development
University of Maryland School of Medicine
Baltimore
MD 21201
USA
Name/email consistency: high
- 3',5'-Cyclic diguanylic acid (c-di-GMP) inhibits basal and growth factor-stimulated human colon cancer cell proliferation. Karaolis, D.K., Cheng, K., Lipsky, M., Elnabawi, A., Catalano, J., Hyodo, M., Hayakawa, Y., Raufman, J.P. Biochem. Biophys. Res. Commun. (2005)
- c-di-GMP (3'-5'-cyclic diguanylic acid) inhibits Staphylococcus aureus cell-cell interactions and biofilm formation. Karaolis, D.K., Rashid, M.H., Chythanya, R., Luo, W., Hyodo, M., Hayakawa, Y. Antimicrob. Agents Chemother. (2005)
- Identification of genes involved in the switch between the smooth and rugose phenotypes of Vibrio cholerae. Rashid, M.H., Rajanna, C., Ali, A., Karaolis, D.K. FEMS Microbiol. Lett. (2003)
- Comparison of Vibrio cholerae pathogenicity islands in sixth and seventh pandemic strains. Karaolis, D.K., Lan, R., Kaper, J.B., Reeves, P.R. Infect. Immun. (2001)
- A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria. Karaolis, D.K., Somara, S., Maneval, D.R., Johnson, J.A., Kaper, J.B. Nature (1999)
- A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains. Karaolis, D.K., Johnson, J.A., Bailey, C.C., Boedeker, E.C., Kaper, J.B., Reeves, P.R. Proc. Natl. Acad. Sci. U.S.A. (1998)